FORM 10-QSB







September 30, 2004















001-14297





DAVI SKIN, INC.







Nevada   86-0907471











301 North Canon Drive, Suite 328, Beverly Hills, CA 90210







(310) 205-9906







_______________________________________________







X





10,713,360 Shares of Common Stock outstanding as of October 30, 2004.







1





Item 1.  Financial Statements.

















2




DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)





CONSOLIDATED BALANCE SHEET


SEPTEMBER 30, 2004


(Unaudited)





**ASSETS**Current assetsCash
$
33,208Certificate of deposit

451,262Prepaid expenses

12,450496,920Fixed assets, net of accumulated depreciation of $2,229

23,291TOTAL ASSETS
$
520,211**LIABILITES AND STOCKHOLDERS' EQUITY**Current liabilitiesAccounts payable
$
26,820Note payable - related parties

205,000TOTAL CURRENT LIABILITIES

231,820Stockholders' equityPreferred stock; $.001 par value; 10,000,000 shares authorized,and no shares issued and outstanding

0Common stock; $.001 par value; 90,000,000 shares authorized10,715,667 shares issued and outstanding

10,716Additional paid-in capital

3,690,347Prepaid consulting expenses

(1,939,323)Accumulated deficit during development stage

(1,473,349)TOTAL STOCKHOLDERS' EQUITY

288,391TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$
520,211








F-1




DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)





CONSOLIDATED STATEMENTS OF OPERATIONS


(Unaudited)





For thePeriod fromMarch 21, 2004Three                  Date of inceptionMonths ended                   throughSeptember 30,             September 302004                              2004Revenues
$
0

$
0Cost of revenues

0


0Gross profit (Loss)

0


0Operating expensesSelling, general and administrative

52,126


227,882Depreciation

1,229


2,228Consulting fees

716,848


716,848Professional fees

524,784


524,7841,294,987


1,471,742Income (Loss) From OperationsOther income (expenses)Interest expenses

(5,000
)

(5,000)Interest income

2,519


3,393(2,481
)

(1,607)NET INCOME (LOSS)

(1,297,468
)

(1,473,349)Basic income (loss) per common share
$
(0.12
)
$
(0.14)Diluted income (loss) per common share
$
(0.12
)
$
(0.14)Basic weighted average common shares outstanding

1,691,491


10,105,257Diluted weighted average common shares outstanding

11,090,291


10,504,057
  F-2


DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)





CONSOLIDATED STATEMENTS OF CASH FLOWS


(Unaudited)


For thePeriod fromMarch 21, 2004Date of inceptionthroughSeptember 30,2004OPERATING ACTIVITIES
$
(1,473,349)Net income (loss)Adjustments to reconcile net income (loss)to net cash used in operating activities:Stock-based conpensation and expenses

1,246,005Depreciation and amortization

2,229Accrued interest

5,000Changed in operating assets and liabilities:Prepaid expenses

(12,450)Accounts payable

26,820Net Cash Provided (Used) ByOperating Activities

(205,745)INVESTING ACTIVITIESCash outlay for certificate of deposit

(500,874)Purchase of fixed assets

(25,520)Net Cash Provided (Used) ByInvesting Activities

(526,395)FINANCING ACTIVITIESProceeds from issuance

765,348Net Cash Provided (Used) byFinancing Activities

765,348Net change in cash and cash equivalents

33,208Cash beginning of period

0Cash end of period
$
33,208











F-3




DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)




NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


(Unaudited)








Description of business, History and summary of significant policies





Description of business





History ,





Development stage company





Going concern





Definition of fiscal year





Use of estimates





Revenue recognition


F-4




DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)





NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)


(Unaudited)








Description of business, History and summary of significant policies (continued)





Fixed assets










Fair value of financial instruments





Earnings (loss) per share





Income taxes










Comprehensive income (loss)





Advertising costs


F-5




DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)





NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)


(Unaudited)








Description of business, History and summary of significant policies (continued)





Stock-based compensation















New accounting pronouncements










FIXED ASSETS.












14,818




2,229









F-6




DAVISKIN, INC.


(formerly MW Medical, Inc.)


(A Development Stage Company)





NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)


(Unaudited)











PREPAID EXPENSES.














CAPITAL STOCK TRANSACTIONS.





Preferred stock





Common stock














COMMON STOCK OPTIONS








F-7  Item 2.   Managements Discussion and Analysis of Financial Condition and Results of Operations.






























Plan of Operations










1.     Development






3


















































2.     Manufacture






4




















3.     Marketing and Distribution














Prior Business Operations










Reverse Stock Split










Merger with Davi Skin, Inc.







5




















Title of Class
Name and Address of
Beneficial Owner
Amount and Nature
Of Beneficial Owner
Percent
of Class(1)Common Stock
Parrish Medley
301 North Canon Drive, Suite 328,
Beverly Hills, CA 90210
1,718,935
16.5%Common Stock
Carlo Mondavi
301 North Canon Drive, Suite 328,
Beverly Hills, CA 90210
5,068,908
48.8%Common Stock
Josh Levine
301 North Canon Drive, Suite 328,
Beverly Hills, CA 90210
1,145,957
11.0%Common Stock
Margaret Robley
301 North Canon Drive, Suite 328,
Beverly Hills, CA 90210
0
0%Common Stock
All executive officers and directors as a group
7,933,800
76.4%





(1)





Executive Officers and Directors










Name
Age
PositionParrish Medley
42
Director, President, CEOCarlo Mondavi
24
Director, Chairman of the BoardJosh Levine
25
Director, Secretary and TreasurerMargaret Robley
60
Chief Financial Officer





6







Carlo Mondavi





Parrish Medley





Josh Levine





Margaret Robley





Assets










Liabilities and Stockholders Equity












7



















Results of Operations

















Liquidity and Capital Resources









Forward-Looking Statements






8  ITEM 3.  CONTROLS AND PROCEDURES.












9  PART II - OTHER INFORMATION





Item 1.  Legal Proceedings:




















Item 2.  Unregistered Sales of Equity Securities Use of Proceeds:










Item 3. Defaults Upon Senior Securities:





None





Item 4.  Submission of Matters to a Vote of Security Holders:





None





Item 5.   Other Information:





None





Item 6. Exhibits





Exhibit Number
Description31.1
Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 200231.2
Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 200232.
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





10




SIGNATURES



























/s/ Parrish Medley




11